Comprehensive, up-to-date information on HIV/AIDS treatment and prevention from the University of California San Francisco

Editors' Picks

• Ward 86 Management Recommendations
  New Topic on Immediate ART Initiation; Susa Coffey, MD; Oliver Bacon, MD; 4/02/2019
• New ARV Profile: Doravirine
  Susa Coffey, MD; 10/08/2018.
• New Topics in HIV Meds Updates: Rapid ART; Dolutegravir, TAF, and Darunavir; U=U in PARTNER2 Study; Others
  Susa Coffey, MD; Jennifer Cocohoba, PharmD; 9/24/2018.
• Opioids and HIV
  UCSF Center for AIDS Research Symposium; 5/11/2018.
• ARV Profile: Bictegravir
  Susa Coffey, MD; 2/21/2018.
• The Clinical Edge: Undetectable Equals Untransmittable
  Matthew Spinelli, MD; Monica Gandhi, MD, MPH; 1/23/2018.

NewsWatch

• FDA Approves First 2-Drug Complete Regimen for HIV-Infected Patients Who Have Never Received Antiretroviral Treatment
  U.S. Food and Drug Administration, 04/09/2019.
• In World First, HIV-Positive Woman Donates Kidney to HIV-Positive Recipient
  CNN, 03/28/2019.
• Majority of Adolescent Sexual Minority Males Do Not Test for HIV
  Medical Bag, 03/27/2019.
• CDC Report Shows 80% of HIV Transmissions in U.S. Come from People Who Have Not Been Diagnosed
  Daily Mail, 03/18/2019.
• This HIV Pill Saves Lives. So Why Is It So Hard to Get in the Deep South?
  Washington Post, 03/12/2019.
• Trump's Budget Offers $291M to Fight HIV in U.S. but Trims Overseas Efforts
  Kaiser Health News, 03/12/2019.
• PrEP Use Jumps to 35 Percent among Gay and Bi Men at Risk of HIV
  NBC News, 03/08/2019.
• Full NewsWatch Coverage